Edition:
United States

FDA Approves New Treatment For Pediatric Patients With Type 2 Diabetes


Monday, 17 Jun 2019 03:26pm EDT 

June 17 (Reuters) - U.S. Food and Drug Administration::FDA APPROVES NEW TREATMENT FOR PEDIATRIC PATIENTS WITH TYPE 2 DIABETES.U.S. FDA - APPROVED VICTOZA (LIRAGLUTIDE) INJECTION FOR TREATMENT OF PEDIATRIC PATIENTS 10 YEARS OR OLDER WITH TYPE 2 DIABETES.FDA - APPROVAL OF VICTOZA WAS GRANTED TO NOVO NORDISK.U.S. FDA - PRESCRIBING INFORMATION FOR VICTOZA INCLUDES BOXED WARNING TO ADVISE ABOUT INCREASED RISK OF THYROID C-CELL TUMORS.